Skip to content

MEDMEDI

Active
Private limited companyfounded 20223 yrs activeRue Albert Lemal 10, 7181 Seneffe, BelgiumKBO/BCE: BE 0795.310.324

MEDMEDI has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €17k and a net result of €11k. Equity is growing by ~9% per year across the filed fiscal years. Its solvency ranks better than 29% of 16922 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
83 / 100
Excellent▼ -10 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency62▼-38
Growth52=
Stability94
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2k at 30 days acceptable
Liquidity tight (current ratio 1.46 against 3.32 in 2024), and 67.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 62
Relative position
BE, all sectors
reference
Sector 62
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 17-12-2025, 45 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
45 d early
2024
7 d early
2023
19 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close13-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€17k▼ 28.0%
2024 · €24k
2023: €14k 2024: €24k
2023 → 2025
Total assets
€53k▲ 56.1%
2024 · €34k
2023: €27k 2024: €34k
2023 → 2025
Net result
€11k▲ 11.1%
2024 · €10k
2023: €14k 2024: €10k
2023 → 2025
Working capital
€17k▼ 27.3%
2024 · €23k
2023: €14k 2024: €23k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€14k-€24k▲ 69.6%€17k▼ 28.0%
Operating result€19k-€14k▼ 26.7%€15k▲ 10.4%
Net result€14k-€10k▼ 30.4%€11k▲ 11.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€5k€10k€15k€20kOperating result 2023: €19k€19kNet result 2023: €14k€14kOperating result 2024: €14k€14kNet result 2024: €10k€10kOperating result 2025: €15k€15kNet result 2025: €11k€11k202320242025
The operating result recovers in 2025; 2025 is 10% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €53k
Fixed assets €899▼ 39.8%
Current assets €52k▲ 60.5%
Equity and liabilities €53k
Equity €17k▼ 28.0%
Debt €36k▲ 264%
The debt ratio rises from 28.8% to 67.2%: debt grows while equity shrinks.
Key figures and ratios
2025 value · change against 2024
EBITDA
€16k
2024 · €14k
Cash flow
€12k
2024 · €10k
Solvency
32.8%
2024 · 71.2%
Current ratio
1.46
2024 · 3.32
Quick ratio
1.33
2024 · 2.55
Debt / equity
2.04
2024 · 0.40
ROE
63.4%
2024 · 41.0%
ROA
20.8%
2024 · 29.2%
Interest coverage
126.73
2024 · 286.24
Debt
€36k
2024 · €10k
Debt ≤ 1 year
€36k
2024 · €10k
Income taxes
€5k
2024 · €4k
Staff costs
€6k
2024 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€34k€53k
Fixed assets21/28€1k€899
Tangible fixed assets22/27€1k€899
Plant, machinery and equipment23€418€899
Furniture and vehicles24€1k-
Current assets29/58€33k€52k
Stocks and contracts in progress3€8k€5k
Stocks30/36€8k€5k
Amounts receivable within one year40/41€12k€33k
Trade receivables40€6k€12k
Other amounts receivable41€6k€21k
Cash at bank and in hand54/58€13k€15k
Equity and liabilities
Total equity and liabilities10/49€34k€53k
Equity10/15€24k€17k
Contributions10/11-€3k
Profit (loss) carried forward14€24k€14k
Amounts payable17/49€10k€36k
Amounts payable within one year42/48€10k€36k
Trade debts44€1k€5k
Suppliers440/4€1k€5k
Taxes, remuneration and social security45€8k€13k
Taxes450/3€6k€13k
Remuneration and social security454/9€2k-
Other amounts payable47/48€693€18k
Income statement Code20242025
Remuneration, social security and pensions62€8k€6k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€290€595
Other operating charges640/8€564€739
Gross operating margin9900€23k€23k
Operating profit (loss)9901€14k€15k
Financial income75/76B€32€902
Recurring financial income75€32€902
Financial charges65/66B€48€123
Recurring financial charges65€48€123
Profit (loss) for the period before taxes9903€14k€16k
Income taxes67/77€4k€5k
Profit (loss) for the period9904€10k€11k
Profit (loss) for the period to be appropriated9905€10k€11k
Appropriation of the result
Profit (loss) to be appropriated9906€24k€35k
Profit (loss) brought forward from the previous period14P€14k€24k
Profit to be distributed694/7-€21k
Return on contributions (dividend)694-€21k

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2025
17-12
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
24-01
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial Weakest financial yearnet €10k ▼30.4%
Net result drops to €10k, the lowest in the series; recovery starts the following year.
12-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Seneffe · 1 establishment unit since 2023
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Albert Lemal 107181 Seneffe
Ground area
451 m²
Building footprint
102 m²
Parcel 52003B0385/00K003, Wallonia. Linked by address, not a title deed.
1 establishment unit
MEDMEDI
Rue Albert Lemal 10, 7181 SeneffeWholesale of pharmaceutical and medical goods
since 20232.340.341.764
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52003B0385/00K003 Wallonia 451 m² 1 · 102 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

894500KFDEUWWDIKJB48
live in the LEI register

Similar companies · same sector, comparable size

Of 16,811 companies in sector 62100 we hold annual accounts for 8,749. 5,526 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded23-12-2022
Fiscal year end30-06
Activities, NACEBEL
62010Computer programming, consultancy and related activities
62900Other information technology and computer services
62100Computer programming
46460Wholesale of pharmaceutical and medical goods
46500Wholesale of information and communication equipment
46510Wholesale trade
62020IT consultancy
62200Computer consultancy and computer facilities management
68201Renting and operating of own or leased residential real estate, excluding social housing
82100Office administrative and support services
82110Office administrative, office support and other business support activities
86230Dental practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

3 entries
Establishment Seneffe 2.340.341.764
E-mail:contact@medmedi.be
Establishment Seneffe 2.340.341.764
Phone:0485921383
Establishment Seneffe 2.340.341.764